Targeting the tumor microenvironment by intervention in interleukin-1 biology

Keyphrases

• Tumor Microenvironment 100%
• Interleukin-1β 100%
• Inflammation 15%
• Interleukin-1 Receptor Antagonist (IL-1Ra) 15%
• In Cancer 10%
• Cancer Patients 10%
• Agonistic 10%
• Tumor Immunity 10%
• Malignant Process 10%
• Invasiveness 5%
• Effective Means 5%
• Malignant Cells 5%
• FDA-approved Drugs 5%
• Biological Activity 5%
• Rheumatoid Arthritis 5%
• Tumor Immunology 5%
• Tumor Development 5%
• Immunosuppression 5%
• Tumorigenesis 5%
• Cell Membrane 5%
• Debulk 5%
• Tumor Stage 5%
• First-line Therapy 5%
• Achivement 5%
• Tumor Site 5%
• Membrane-associated 5%
• Tumor Treatment 5%
• Associated Forms 5%
• Tumor Mass 5%
• Specific Antibodies 5%
• Immunosuppressive Cytokines 5%
• Anti-interleukin-1 5%
• Compartmentalization 5%
• Myeloid Cells 5%
• Invasive Tumors 5%
• Signaling Receptor 5%
• Autoinflammatory Diseases 5%
• Antitumor Immune Response 5%
• Interleukin-1 Signaling 5%
• Active-only 5%
• Secreted Molecules 5%
• Tumor Invasiveness 5%
• Anti-interleukin-1 Treatment 5%
• Transmition 5%
• Immunostimulatory 5%
• Decoy 5%

Immunology and Microbiology

• Interleukin 1 100%
• Immunosuppression 9%
• Tumor Immunity 9%
• Monospecific Antibody 4%
• Myeloid 4%
• Immune Response 4%
• Cytokine 4%
• Interleukin-1 4%
• Interleukin 1 Receptor Antagonist 4%
• Neutralization 4%
• Cell Membrane 4%
• Cytosol 4%
• Inflammatory Arthritis 4%
• Biological Activity 4%
• Autoinflammatory Syndromes 4%